Scott DeNobile

Vice President, Trade and Distribution at BridgeBio

Speaker

Scott DeNobile has over 30 years of experience in the pharmaceutical industry, with more than 20 years focused on Market Access. He began his career at Berlex Labs, where he was part of the launch of Betaseron—considered the first limited distribution drug in the U.S. Scott has held roles at major pharmaceutical companies including Bristol-Myers Squibb, SuperGen, Merck, Pharmacyclics, Neurocrine Biosciences, and Urovant. For the past five years, he has served as Vice President of Trade and Distribution at BridgeBio.